The Interplay Between Replication Capacity of HIV-1 and Surrogate Markers of Disease

被引:3
|
作者
Rindler, Audrey E. [1 ,2 ,3 ]
Kusejko, Katharina [1 ,2 ]
Kuster, Herbert [1 ,2 ]
Neumann, Kathrin [1 ,2 ]
Leemann, Christine [1 ,2 ]
Zeeb, Marius [1 ,2 ,3 ]
Chaudron, Sandra E. [1 ,2 ,3 ]
Braun, Dominique L. [1 ,2 ]
Kouyos, Roger D. [1 ,2 ]
Metzner, Karin J. [1 ,2 ]
Gunthard, Huldrych F. [1 ,2 ]
机构
[1] Univ Zurich, Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[2] Univ Zurich, Inst Med Virol, Zurich, Switzerland
[3] Univ Zurich, Life Sci Zurich Grad Sch, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
HIV-1; replication capacity; primary HIV-1 isolates; set point viral load; diversity; EARLY ANTIRETROVIRAL THERAPY; INFECTION; VIRULENCE; TRANSMISSION; EFFICIENCY; DIVERSITY; FITNESS; ADULTS; LOAD;
D O I
10.1093/infdis/jiac100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background HIV-1 replication capacity (RC) of transmitted/founder viruses may influence the further course of HIV-1 infection. Methods RCs of 355 whole-genome primary HIV-1 isolates derived from samples acquired during acute and recent primary HIV-1 infection (PHI) were determined using a novel high-throughput infection assay in primary cells. The RCs were used to elucidate potential factors that could be associated with RC during PHI. Results Increased RC was found to be associated with increased set point viral load (VL), and significant differences in RCs among 13 different HIV-1 subtypes were discerned. Notably, we observed an increase in RCs for primary HIV-1 isolates of HIV-1 subtype B over a 17-year period. Associations were not observed between RC and CD4 count at sample date of RC measurement, CD4 recovery after initiation of antiretroviral treatment, CD4 decline in untreated individuals, and acute retroviral syndrome severity scores. Conclusions These findings highlight that RCs of primary HIV-1 isolates acquired during the acute and recent phase of infection are more associated with viral factors, that is set point VL, than with host factors. Furthermore, we observed a temporal increase in RC for HIV-1 subtype B viruses over a period of 17 years. Using 355 primary HIV-1 isolates of acute and recently HIV-1-infected patients, we elucidated that replication capacity is associated with set point viral load, HIV-1 subtype, and viral diversity, as well as calendar year.
引用
收藏
页码:1057 / 1068
页数:12
相关论文
共 50 条
  • [21] Synonymous Codon Pair Recoding of the HIV-1 env Gene Affects Virus Replication Capacity
    Jordan-Paiz, Ana
    Franco, Sandra
    Martinez, Miguel Angel
    CELLS, 2021, 10 (07)
  • [22] Reduced Replication Capacity of NL4-3 Recombinant Viruses Encoding Reverse Transcriptase-Integrase Sequences From HIV-1 Elite Controllers
    Brumme, Zabrina L.
    Li, Chun
    Miura, Toshiyuki
    Sela, Jennifer
    Rosato, Pamela C.
    Brumme, Chanson J.
    Markle, Tristan J.
    Martin, Eric
    Block, Brian L.
    Trocha, Alicja
    Kadie, Carl M.
    Allen, Todd M.
    Pereyra, Florencia
    Heckerman, David
    Walker, Bruce D.
    Brockman, Mark A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (02) : 100 - 108
  • [23] Assessing Predicted HIV-1 Replicative Capacity in a Clinical Setting
    Kouyos, Roger D.
    von Wyl, Viktor
    Hinkley, Trevor
    Petropoulos, Christos J.
    Haddad, Mojgan
    Whitcomb, Jeannette M.
    Boeni, Juerg
    Yerly, Sabine
    Cellerai, Cristina
    Klimkait, Thomas
    Guenthard, Huldrych F.
    Bonhoeffer, Sebastian
    PLOS PATHOGENS, 2011, 7 (11)
  • [24] Country Level Diversity of the HIV-1 Pandemic between 1990 and 2015
    Hemelaar, Joris
    Loganathan, Shanghavie
    Elangovan, Ramyiadarsini
    Yun, Jason
    Dickson-Tetteh, Leslie
    Kirtley, Shona
    JOURNAL OF VIROLOGY, 2021, 95 (02)
  • [25] Correlations Between HIV-1 Clades and HIV-1 Antibody Neutralization Sensitivity: Significant for Vaccine Development?
    van Gils, Marit J.
    Schuitemaker, Hanneke
    CURRENT HIV RESEARCH, 2010, 8 (08) : 579 - 586
  • [26] LONG-TERM TREATMENT OF ANTIGENEMIC HIV-1 INFECTED CHILDREN WITH ZIDOVUDINE - ASSESSMENT OF TOXICITY AND OF DISEASE SURROGATE MARKERS
    DEMARIA, A
    FERRAZIN, A
    LOY, A
    CIRAVEGNA, B
    BARIGIONE, GD
    FIOREDDA, F
    CIRILLO, C
    TERRAGNA, A
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1992, 18 (03): : 280 - 286
  • [27] Herpes Simplex Virus: The Interplay Between HSV, Host, and HIV-1
    Desai, Dipen Vijay
    Kulkarni, Smita Shrikant
    VIRAL IMMUNOLOGY, 2015, 28 (10) : 546 - 555
  • [28] Diminished transmission of drug resistant HIV-1 variants with reduced replication capacity in a human transmission model
    Marieke Pingen
    Ramin Sarrami-Forooshani
    Annemarie MJ Wensing
    Petra van Ham
    Agata Drewniak
    Charles AB Boucher
    Teunis BH Geijtenbeek
    Monique Nijhuis
    Retrovirology, 11
  • [29] HIV-1 fitness and replication capacity: What are they and can they help in patient management?
    Frank Maldarelli
    Current Infectious Disease Reports, 2003, 5 (1) : 77 - 84
  • [30] Inhibition of HIV-1 Replication by Isoxazolidine and Isoxazole Sulfonamides
    Loh, Belinda
    Vozzolo, Luciano
    Mok, B. James
    Lee, Chien Chi
    Fitzmaurice, Richard J.
    Caddick, Stephen
    Fassati, Ariberto
    CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 75 (05) : 461 - 474